The researchers say that the findings pave the way to generating new and important information about the development chronic kidney disease (CKD) and hypertension (HTN) in cats.
The RVC says that about 30% of cats aged 10 years or older have CKD, which equates to approximately 600,000 in the UK.
Of these, about 40% will also have hypertension.
The research team was led by principal investigator at the RVC, Dr Rosanne Jepson, alongside joint first author from Queen Mary University of London, Dr Helen Warren, and Professor Patricia Munroe.
The team examined the archives of 1,022 domestic cats seen at both the RVC’s Beaumont Sainsbury Animal Hospital and Bow PDSA Pet Hospital since 1992, looking for genetic associations with CKD and HTN using a genome-wide association study (GWAS) approach.
The GWAS approach used a special feline array to characterise over 63,000 genetic differences across the feline genome.
The team examined the influence of different genes on disease traits which may point to new ways of treatment as the pathways and proteins controlled by these genes can indicate novel mechanisms for disease development.
Researchers say that this study method has historically been used for rarer and breed-specific conditions where single genetic mutations might be occurring.
However, the findings show it could now be used to generate new information about common and complex diseases which are likely to be the result of genetic, lifestyle and environmental risks.
Rosanne Jepson, Principal Author of the paper and Associate Professor in Small Animal Internal Medicine at the RVC, said: “This was an exciting opportunity to explore potential genetic influences on the development of chronic kidney disease and systemic hypertension in cats, collaborating with key opinion leaders who work and have published extensively in this field in human medicine.
“These conditions are complex - meaning that there are many factors relating to genetics, lifestyle and environment that cumulatively determine whether an individual may develop either CKD or hypertension in their lifetime.
“This study has shown us, as proof of concept, that large scale genomic studies will be important for understanding the pathogenesis of such complex disease conditions and may help to identify novel pathways as targets for diagnosis and management in the future.”
Andrew Groom has been appointed as the new Country Manager for Kruuse UK Ltd based near York, following the promotion of Lars Lund and his relocation back to Kruuse A/S in Denmark. Andrew takes up this new position to head up the UK sales and marketing team and to help implement the expansion programme within the veterinary and pet markets that Kruuse has planned for 2008.
Having studied agriculture and gaining a DHM, Andrew managed large farming operations, as well as being a contributing writer for the agricultural journal “Farmers Weekly”. He then continued his education by studying commercial management at Circencester College from where he went to United Milk as a Farm Liaison manager and commercial manager. His career progressed when in 2004, he joined Arnolds Veterinary Products as sales manager.
“I have known about Kruuse and its wide range of products for many years and have always admired the company’s vision in bringing innovative products onto the market for both the large and small animal sectors, including high quality pet toys and accessories,” said Andrew. “So when an opportunity arose to work for Kruuse in the UK, I did not need much persuading to apply for the job.”
“Andrew’s vast experience in both large and small animal industries will prove a real asset in all of the important market areas in which Kruuse operates,” commented Hans Alsted, Kruuse A/S Export Director.
Bayer Animal Health, maker of Advocate, has announced that it will be running its 'Be Lungworm Aware' campaign in April.
The company says the campaign aims to help raise awareness of Angiostrongylus vasorum amongst dog owners and support the veterinary practice as a source of further information. The initiative will be backed by a national TV and print advertising campaign. Media vet Joe Inglis will also be supporting the initiative and will be talking about Angiostrongylus vasorum during a series of radio and web broadcasts.
Bayer has produced new support materials, including an updated lungworm PR pack. The materials are designed to allow veterinary practices to educate owners on the disease, whilst helping to raise the profile of the practice in the local community.
Meanwhile, the research carried out by the company has revealed some interesting insights into dog owners' understanding of lungworm.
Despite awareness being fairly high with nearly half of owners claiming to know about the condition, 84% of this group did not know any of the clinical signs associated with the infection, while only 60% were aware that the disease could be fatal if left untreated. Understanding of how dogs become infected was also relatively low with only 24% of owners recognising the role of slugs and snails as the intermediate host for the parasite. As well as playing a vital role in alerting owners to the emergence of the disease, the veterinary practice was cited as the primary source of information that owners would refer to if they needed advice on treating this parasite.
Eric Morgan from the University of Bristol said: "Angiostrongylus vasorum appears to be continuing its spread to new locations in the UK. It is therefore important that dog owners are educated on the infection and the signs to look out for, to enable them to seek treatment before it is too late."
For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.
Alex is applying the data science he uses in his day job to help local vets at the Olive Ridley Project care for the ancient reptiles.
Six of the seven species of sea turtles are endangered due to human behaviour, many of them killed by poachers for their shells, eggs and meat.
They're also affected by the increasing volume of plastic waste in the sea.
Alex, who normally spends his time leading a team of business intelligence engineers and analysts who provide insights in finance, HR and clinical event reporting, is setting the charity up with practice management software to help it capture clinical records and track the sea turtles.
Alex said: "We’ll be setting up the software, making sure the vets can operate it and then adding all their existing data to it. We’re giving them a powerful tool to capture clinical records and manage turtles over a long period of time.”
“These valuable creatures are hugely important to marine ecosystems and have travelled our seas for the last 100 million years, so I’m delighted to be able to play a part in their conservation.”
For more information on the Olive Ridley Project, visit https://oliveridleyproject.org.
Although developed by the RCVS and VSC BAME Student Support Working Group ostensibly for use by Universities, EMS placement host practices and other educational establishments, it is recommended that all veterinary practices review the guidance.
The Guidance on Religious Clothing and Beliefs covers issues such as: balancing accommodations for religious dress with clinical considerations, and making accommodations for religious observance in academic timetabling and exams.
Gurpreet Gill, RCVS Leadership and Inclusion Manager said: “This document is about recognising that personal religious beliefs should be respected and accommodated as far as possible, while also not compromising professional responsibilities such as infection control, effective communication and the health and safety of individuals and their colleagues.
"Most importantly, it is about creating a welcoming and inclusive environment and ensuring that all students are able to express their religious identity whilst participating in educational and workplace settings.
“Although the guidance is not exhaustive, we would highly recommend that, where relevant, educators, practices and other veterinary workplaces review, adopt and adapt this guidance for their own settings to ensure that all members of the professions are welcomed and included.”
The Guidance on Religious Clothing is available to download from: https://www.rcvs.org.uk/news-and-views/publications/guidance-on-religious-clothing-and-beliefs/
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."
PBD Biotech says the Actiphage test offers the potential to revolutionise control of bovine TB by allowing detection of the disease within hours from a blood or milk sample.
Last November, the Welsh Government announced a new policy that allowed the use of non-validated tests such as Actiphage in herds affected by a TB breakdown. It followed a similar protocol to one authorised by the UK Government last year for cattle herds in England after the test was used as part of a successful private eradication plan on a Devon dairy farm.
Mossman Farming, in Ceredigion, is located in an area of chronic breakdown. It is a spring-calving milking herd with a total stock of 529, to date 312 dairy cows have been slaughtered. Farmer Chris Mossman agreed to trial Actiphage after hearing about the Gatcombe pilot.
Chris said: "TB is a massive problem in Ceredigion, so when I heard about Actiphage’s use at Gatacombe, helping to clear that dairy herd for the first time in six years, I wanted to try and replicate those findings here. Me – and many other farmers – are losing large numbers of animals. I’m trying to do all I can to get rid of this disease from my herd."
In Spring 2019, The Office of the Chief Veterinary Officer for Wales granted permission for Robert Price-Jones MRCVS to use Actiphage to screen high-risk cattle for M. bovis.
Robert, who has been leading the trial, said: "Actiphage is able to identify the presence of relatively low numbers of M. bovis in the blood stream of infected cattle. It is not dependent upon an immune system response to the pathogen - in contrast to current validated tests - and so has greater sensitivity than such as the official Tuberculin SICCT skin test.
"The benefit of using Actiphage is that it offers the potential for eradicating the disease from the farm; as early identification of animals at risk of bovine TB enables heightened disease management and control."
Under the terms of the Welsh Government’s protocol, cattle not condemned for slaughter can be tested with Actiphage. Those that give a positive result are identified with a ‘management’ marker, monitored and milked separately.
To prevent further contamination of the environment and to minimise risk to uninfected cattle, animals found to be ‘shedders’ are removed from the farm.
Although a decision to remove cattle based on a non-validated test will be at the farmers’ own expense, the APHA (Animal and Plant Health Agency) has confirmed that during the trial, where a positive result is confirmed with statutory tests, the animals will be removed with compensation as normal.
So far, 100 animals from Mossman Farming have been tested with Actiphage and Robert Price-Jones is preparing a paper to publish the findings in early 2020.
PBD Biotech is now seeking more farms to trial Actiphage in order to gain the World Organisation for Animal Health (OIE) validation. The company is offering reduced cost testing to support trials where the findings are made available to support validation of the test.
The programme is the first in a new series of ‘Accelerated’ courses from the company, designed to support those starting out on their postgraduate learning journey or experienced vets who want to refresh their knowledge in a specific subject.
The Accelerated Emergency and Critical Care programme comprises 15 modules covering pathophysiology, diagnosis, management and current treatments.
The modules are delivered on a weekly basis and delegates can study at their own pace. Delegates can also access all the modules for a 12-month period so they can revisit the contents as necessary.
In addition to the modules, delegates have access to a discussion forum and four live sessions with Specialists for clinical case discussions.
At the end of the course, delegates can take a Foundation Certificate from the International School of Veterinary Postgraduate Studies (ISVPS).
The programme was developed by Specialist veterinarians, both Fellows and Members of the Australian and New Zealand College of Veterinary Scientists in Emergency and Critical Care, from Improve International’s Australian Partner, the Animal Emergency Service.
David Babington MRCVS, Business Development Director at Improve International, said: “The growing interest we are seeing from veterinarians around the world in updating their knowledge as we prepare to emerge into the post-COVID world, was the catalyst for the creation of our new Accelerated online course range.
"The Accelerated Emergency and Critical Care Programme is ideal for veterinarians at all stages of their career. It is an example of the ways we are delivering on our strategy of significantly expanding our e-learning portfolio and harnessing technologies, including video teaching and virtual/augmented reality, to offer a more engaging, affordable, accessible and rich learning experience to veterinary professionals around the world."
A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
Since qualifying as an RVN in 1998, Georgina, aka George, has had a number of veterinary management roles, including Head Nurse, Business Support Manager and Regional Operations Manager.
She is currently Practice Director for Irby and Neston Vets in Cheshire.
George joined the VMG Board in 2016 and takes over as President from Richard Casey, who becomes Senior Vice President of the association.
Stuart Saunders, Practice Manager at Devon-based Selworthy Vets, becomes Junior Vice President.
All will serve a one-year term.
George said: “Becoming a manager or leader has an impact on the individual, but has an even stronger impact on the work and day-to-day experience of those around them.
"These roles therefore bring with them a great responsibility to do them well.
“We know from our members that the support, teaching, coaching and other resources that the VMG offers are making a positive difference and I’m particularly excited to take on the presidency following the recent launch of our Certificate of Veterinary Leadership & Management, an accredited taught qualification.
"I believe rigorous qualifications are the most effectively way to create the 21st century leaders and managers the veterinary sector needs.
“During my presidency, I will continue to focus on extending the range of support and help we offer to leaders and managers."
To use the service, practices have to register for VetsDeliver via Easy Direct Debit (which handles payments), then configure the system for the number of consultation rooms needed and to add practice branding. The first consultation room costs £69 per month, with discounts for subsequent rooms.
Practices can promote the service to pet owners by sharing a link for appointments via social media, the practice website, or a mail out to clients.
Clients then follow the shared link, complete a form and book a consultation slot.
After the consultation, the practice can email a link to the pet owner so that they can pay for any medication.
Adrian Tantrum (that must have been quite a cross to bear at school), Head of the Companion Animal Business Unit at MSD Animal Health said: "As market leaders, with brands such as Bravecto, Nobivac and Caninsulin, we want to help practices adapt to the new normal.
"We have listened to feedback from practices around what they want from a telemedicine platform and worked with EDD to create a simple and easy to use service. This will allow practices to provide pet owners with the support they need, whether it be their parasiticide prescriptions or providing continuity of care for diabetic patients, and will of course bring much-needed cash flow into their practices.
"We've chosen Zoom for the video capabilities as it is one of the most popular video conference apps with millions of users worldwide, so we know it's familiar to most pet owners."
Adrian added: "As we all adjust to new ways of working we are putting in place a whole series of new services for practices that will help bring them closer to their clients and allow them to continue to provide pet owners with the expertise and support they need. Being able to see a vet 'face-to-face', if not in the flesh, will be reassuring for a lot of pet owners who will be worrying about both new and on-going conditions."
For more information, contact your MSD account manager.
If they become law, the changes proposed by the working party will have a profound effect on all practising veterinary surgeons and nurses, so it could not be more important that you express your opinion, whether that is in support of the changes or against them.
The proposals fall under five main headings below, each of which is linked to a discussion thread on the subject. Of particular note is the 'fitness to practise' section which includes proposals for radical changes to the disciplinary process:
Do come and join in the discussions. Which of these things do you think will improve the veterinary care of animals? Could any of them have consequences that haven't been thought of? Do you think some of them show the College overreaching itself? Or do they not go far enough?
Come and tell us what you think. Hopefully the discussions will help you form your response to the RCVS survey.
The RCVS survey closes at 5pm on 23rd April 2021.
Vets4Ukraine2022 is the brainchild of a group of twenty veterinary Specialists who are raising money by offering their knowledge and expertise in the form of free CPD delivered online, via Facebook and Linkedin.
So far, they've raised £2,236 for the British Red Cross.
For details of this group's activities and the free CPD it is offering colleagues, visit https://www.facebook.com/groups/1491854917875566/permalink/1497308427330215/
Meanwhile the FECAVA and The Webinar Vet are running the Vets for Ukraine Online Conference, a CPD event online on the 9th April from 10:00am to 10:00pm.
More details of that initiative, which is raising money for the Disasters Emergency Committee and Four Paws can be found here: https://www.thewebinarvet.com/pages/ukraine-veterinary-aid-conference/
Last but not least, British Veterinary Professionals for Ukraine is working to get essential medical supplies - both for animals and humans - delivered to Ukraine.
BVP4U is asking for supplies to be sent to BVP4UA c/o Hoermann Equine,Wrights Lodge East, Oakham Road, Whissendine, Rutland, LE15 7HA.
A list of specific requirements is available on the BVP4UA facebook page https://www.facebook.com/groups/britishvetsforukraine.
Alternatively, veterinary practices can buy supplies through their regular wholesalers (MWI/Covetrus/NVS) and have them delivered direct to BVP4UA by emailing their wholesaler with details of what they want to donate.
Other companies who do not operate through wholesalers may also be prepared to deliver direct.
Cash donations can be made via gofundme> to allow direct purchasing of the most needed veterinary supplies https://gofund.me/f7f25366.
Fitzpatrick Referrals has announced the launch of a new outpatients diagnostic imaging service, available to all primary care veterinary surgeons.
According to the practice, its Siemens CT and closed field MRI scanners are among the most advanced in small animal practice in the world, and enable more accurate and timely diagnosis of both routine and potentially life-threatening conditions, including tumours. The practice is now making these scanners available to outpatients from primary care practices.
The service will be available 7 days a week, from 09:00hrs to 21:00hrs. Primary care vets can access the service directly and schedule an appointment at a time convenient to them and their patient, without the need of referral. The qualified team of radiographers at Fitzpatrick will operate the scanners and all scans will be complemented by detailed imaging reports created and sent electronically by Vet CT Specialists, a teleradiology company headed by radiology specialist Victoria Johnson BVSc DVR DipECVDI MRCVS.
Fitzpatrick Referrals says it acknowledges that many primary care veterinary surgeons do not have the resources to provide advanced diagnostic imaging on site, so it is very pleased to be able to offer its CT and MRI suite to help expedite diagnosis, whilst the patient remains under direct supervision by the referring practice and the patient is immediately returned to their care thereafter. This can be an extension of the service offered by the primary care clinician to the client, hopefully resulting in rapid and appropriate treatment for the patient and expanding the range of services offered by practices to their clients.
Dr Noel Fitzpatrick, Director said: "It's as if the MRI and CT were actually in your own practice, because our facility is just an extension of your care package and you can advertise it as such. This improves the profile of your practice and enhances the bond of the client with the referring practice whilst facilitating appropriate intervention in a timely fashion. All types of scanning, soft tissue, orthopaedic and neurologic, can be catered for and all patients will be cared for and monitored by qualified veterinary nurses at a time to suit the owner. I see this as a win-win situation. If the primary care clinician needs any further help with the case, they can just ask on the day. Seven-day week advanced diagnostic imaging is now within the grasp of each and every practice, marking a new era of an integrated team approach to efficient cost-effective diagnosis and treatment."
To book an appointment, call Fitzpatrick Referrals on 01483 423761 and in due course there will be an online booking facility. For more information on the Outpatients Diagnostic Imaging Service, call Simon Hester on 07802 584133 or visit www.fitzpatrickreferrals.co.uk.
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.
The aim of the ‘Advocates of Knowledge’ CPD lungworm modules is to help vets assess the lungworm risk in their area, recommend prevention and treatment regimes and also to communicate effectively with clients as the UK emerges from lockdown.
In the first module, Dr Jenny Helm, European Specialist in Small Animal Internal Medicine and Senior Veterinary Clinician at the University of Glasgow, tackles questions about lungworm post lockdown, including whether or not pets are at greater risk as a result of changes in their owners' behaviour caused by the pandemic.
The second module, from Dr Simon Tappin, European and RCVS Recognised Specialist in Small Animal Internal Medicine, and Head of Medicine at Dick White Referrals (pictured right), will take the form of an interactive case-based discussion on lungworm. He will use clinical cases to talk through presenting signs, and how to approach investigation of these cases, as well as looking at treatment and prevention strategies.
Vicky McAlister, Senior Brand Manager for Advocate, said: “During lockdown, dog owners have modified their behaviour (including spending more time outdoors with their dogs), and this may have affected the risk of dogs becoming infected with lungworm. So we’re very pleased that, together with our experts, we’re launching informative, engaging and relevant CPD lungworm modules for vets, to help provide them with the information needed, and importantly to encourage communication with dog owners regarding this important subject matter”.
You can sign up for the CPD modules here - https://advocatesofknowledge.vettimes.co.uk.
IIC is an independent customer experience agency which conducts assessments, develops insights and awards annual accreditations to businesses.
For its accreditations, IIC uses feedback from customers, employees and the management team to assess the customer experience delivered by an organisation.
Customer services manager at Pennard Vets, Collette Rednall, who is also an IIC Ambassador, said: “We are the first in our industry to go through the rigorous process and we are thrilled to achieve a gold award.
“There are just 36 businesses in the UK that have achieved gold status – so this a fabulous achievement for every single one of our 100-strong team.”
In 2021 Pennard Vets became the largest veterinary practice in the world to become employee owned, through an Employee Ownership Trust (EOT), meaning its entire team are now practice owners and shareholders in the business.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References
Pet&Vet has the support of the RCVS, BSAVA, BVNA and BVRA and each has a column aimed at giving pet owners their insights along with general veterinary advice.
The quarterly title will also run seasonal features and have sections about products and services, conservation, pet and owner well-being, treatments, pet owner profiles and celebrity interviews.
In issue one, due to arrive in early March, Ricky Gervais talks about his love for animals, and there articles about spotting feline arthritis and how to look after older dogs at home.
The magazine will be distributed to veterinary practices free of charge, and the publishers hope you will put it in your reception area for pet owners to read while they wait.
Practices can order more copies, and the plan is to allow them to sell future issues and take a cut of each sale.
Pet owners can also subscribe to get their own copies.
Most of the content is written by veterinary professionals and the editor, Chris Ritchie, says he is keen to receive contributions for the print magazine and companion website, www.petandvetmag.com, which is due to launch alongside the magazine.
Editorial enquiries: editor@petandvetmag.comCommercial enquiries: davidk@petandvetmag.com.
Camilla, who was shortlisted as a finalist for Innovator of the Year at the 2025 Digital Women Awards, says her mission has always been to give first-opinion vets the tools and confidence to get the most from ultrasound in everyday practice – and the new tool is a big step forward in that vision.
The tool:
Camilla says the final report is fully editable, but much of the “heavy lifting” is done — saving time, reducing second-guessing, and producing reports that are more useful for colleagues, clients, and patient care.
https://www.fovu.co.uk/
https://www.fovu.co.uk/fovu-report-video
BCF Technology has launched a competition in which the person who submits the best photograph with the theme of: All in a day's work - animal imaging, will win an iPad 2.
To enter the competition, you need to post your photographs, (and tell BCF a little about the story behind the images) at www.facebook.com/bcftechnology or email them to: info@bcftechnology.com
Jason Rogers, Marketing Manager at BCF said: "We wanted to create a fun way to show just how interesting and different each days work is when imaging animals. We have made the competition open to all that work with animal imaging including our staff, dealers and vets, vet nurses, animal contractors, etc from all over the world.
"It is great to see the BCF office in the States and our international dealers also promoting the competition in their own countries, making the competition truly international. Response to the competition has been fantastic - see our facebook page to some entries for yourself."
The closing date for the competition is 30th September 2011.
For more information, visit: www.bcftechnology.com
Lord Rooker, Minister for Sustainable Food, Farming and Animal Health has announced seven new members to the Veterinary Residues Committee (VRC).
The VRC’s role is to advise the Chief Executives of the Veterinary Medicines Directorate (VMD) and the Food Standards Agency (FSA) on the formulation of the residues surveillance programmes and on the significance of the results in terms of consumer safety.
The seven new members who have been appointed to serve on the VRC from January 2009 until December 2012 are:
The appointments were undertaken in accordance with the Code of Practice issued by the Office of the Commissioner for Public Appointments.
Intraperitoneal and incisional analgesia in small animals: simple, cost-effective techniques1, considers the findings and limitations of recent studies and makes recommendations on the use of IP and incisional analgesia in companion animals.
Paulo Steagall, lead author of the paper said: "Based on current evidence and a consensus of the WSAVA-GPC members, it is recommended that IP and incisional analgesia should be used for abdominal surgery such as intestinal foreign body removal, splenectomy, etc. These techniques can be particularly useful in high-volume sterilisation programmes due to their safety and cost effectiveness. They should never be administered as stand-alone analgesic techniques, but rather should be used in addition, as part of a multimodal analgesic plan with opioids and nonsteroidal anti-inflammatory drugs (NSAIDs)."
The review says that current literature on IP and incisional analgesia has several limitations including the use of different doses, drugs and volumes of local anaesthetic. Furthermore, acute pain assessment was performed using a number of different pain scoring systems with variable validity, by a number of different people which may introduce bias. Further studies are therefore warranted to continue to investigate the use of IP and incisional analgesia in a number of clinical scenarios.
Nicholas Jeffery, editor of JSAP said: "Local anaesthetics are inexpensive and not limited by geographic availability; this review supports their use to manage perioperative pain as part of a multimodal management approach."
The full article can be found in the January issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13084
For further information relating the use of local anaesthesia and the management of perioperative pain, the BSAVA is advising veterinary surgeons to consult a text such as the BSAVA Guide to Pain Management in Small Animal Practice.
Reference